Markets

Top Ranked Momentum Stocks to Buy for April 30th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, April 30th:

Karyopharm Therapeutics Inc. (KPTI): This pharmaceutical company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.8% over the last 60 days.

Karyopharm Therapeutics Inc. Price and Consensus

Karyopharm Therapeutics Inc. Price and Consensus

Karyopharm Therapeutics Inc. price-consensus-chart | Karyopharm Therapeutics Inc. Quote

Karyopharm's shares gained 16% over the last one month compared to S&P 500’s rise of 14.8%. The company possesses a Momentum Score of A.

Karyopharm Therapeutics Inc. Price

Karyopharm Therapeutics Inc. Price

Karyopharm Therapeutics Inc. price | Karyopharm Therapeutics Inc. Quote

Compugen Ltd. (CGEN): This therapeutic discovery company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.2% over the last 60 days.

Compugen Ltd. Price and Consensus

Compugen Ltd. Price and Consensus

Compugen Ltd. price-consensus-chart | Compugen Ltd. Quote

Compugen’s shares gained more than 100% over the last one month. The company possesses a Momentum Score of A.

Compugen Ltd. Price

Compugen Ltd. Price

Compugen Ltd. price | Compugen Ltd. Quote

AngloGold Ashanti Limited (AU): This gold mining company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.3% over the last 60 days.

AngloGold Ashanti Limited Price and Consensus

AngloGold Ashanti Limited Price and Consensus

AngloGold Ashanti Limited price-consensus-chart | AngloGold Ashanti Limited Quote

AngloGold’s shares gained 40.8% over the last one month. The company possesses a Momentum Score of A.

AngloGold Ashanti Limited Price

AngloGold Ashanti Limited Price

AngloGold Ashanti Limited price | AngloGold Ashanti Limited Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2019, while the S&P 500 gained and impressive +53.6%, five of our strategies returned +65.8%, +97.1%, +118.0%, +175.7% and even +186.7%.

This outperformance has not just been a recent phenomenon. From 2000 – 2019, while the S&P averaged +6.0% per year, our top strategies averaged up to +54.7% per year.

See their latest picks free >>


Click to get this free report

Karyopharm Therapeutics Inc. (KPTI): Free Stock Analysis Report

Compugen Ltd. (CGEN): Free Stock Analysis Report

AngloGold Ashanti Limited (AU): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More